TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks November 11, 2011
TCL Archive Breaking With Tradition, NIH Director Heads Obama’s Search for NCI Director. February 12, 2010
TCL Archive CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans. November 5, 2004
